What is Zhejiang Orient Gene Biotech Co., Ltd's (688298.SS) StockRank?

MoatMap's StockRank for Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) is 42/100, with a Hold signal. This is a composite score combining Quality (39), Value (47), and Momentum (47) factor ranks across MoatMap's 20,000+ stock universe.

Does Zhejiang Orient Gene Biotech Co., Ltd have an economic moat?

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Zhejiang Orient Gene Biotech Co., Ltd a buy, hold, or sell?

MoatMap's current signal for Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Zhejiang Orient Gene Biotech Co., Ltd in?

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688298.SS

HOLDREMOVE

Zhejiang Orient Gene Biotech Co., Ltd · Healthcare · China · $638M · Avg Vol: $7M/d

StockRank

P/E (TTM)

—

ROE

-9.1%

D/E

0.1x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Zhejiang Orient Gene Biotech is an in-vitro diagnostics manufacturer. It is a low-moat business with declining post-COVID revenues and no connection to high-conviction macro themes.

COMPANY DESCRIPTION

Zhejiang Orient Gene Biotech manufactures in-vitro diagnostic products, specializing in rapid test cassettes, molecular diagnostics, and liquid biopsy systems. The company's competitive moat is driven by its massive, export-oriented manufacturing capacity and extensive international regulatory certifications (FDA, CE). It operates as a major global OEM/ODM supplier in the rapid diagnostic testing industry.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	1.3B	121M	122M	140M	-52.4%
EPS	1.82	-0.29	-0.40	-0.44	—
Shares	202M	202M	202M	202M	0.0%
Debt	12M	90M	72M	48M	58.3%
Equity	1.2B	1.1B	982M	886M	-9.8%
Op CF	443M	-243M	-51M	-29M	—
Inv CF	-351M	-313M	-99M	85M	—
Fin CF	-103M	7M	-67M	-35M	—

PRICE (1M)-23.6%

SMA 50SMA 200

$2.85

RSI (14)

23.6

52W High

$4.53

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-9.1%35.1

ROE

-9.1%35.8

GP/Assets

5.9%20.0

Op. Margin

-29.0%24.5

FCF/Assets

-6.4%33.4

Piotroski

—28.7

Int. Cover

-50.0x6.4

D/E Ratio

0.05x73.5

Current Ratio

3.79x62.1

Value

P/E (TTM)

—N/A

EV/EBITDA

-7.4x78.1

P/FCF

—N/A

P/B

0.6x87.9

P/S

3.9x48.2

Div Yield

—N/A

Momentum

52W High %

63%45.4

RS 6M

-32%39.9

SMA 50/200

0.90x34.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+1026%98.5

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$638M

P/E (Forward)

0.7x

Gross Margin

41.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688298.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688298.SS	Zhejiang Orient Gene Biotech Co., Ltd(you)	$638M	42	HOLD
300143.SZ	INKON Life Technology Co., Ltd.	$1.1B	38	HOLD
301370.SZ	GKHT Medical Technology Co., Ltd.	$629M	24	SELL
600055.SS	Beijing Wandong Medical Technology Co.,Ltd.	$1.3B	37	HOLD
300298.SZ	Sinocare Inc.	$1.3B	48	HOLD
9877.HK	Jenscare Scientific Co., Ltd.	$434M	29	SELL
9996.HK	Peijia Medical Limited	$403M	31	SELL
688161.SS	Shandong Weigao Orthopaedic Device Co., Ltd	$1.6B	39	HOLD
688108.SS	Sino Medical Sciences Technology Inc.	$1.4B	36	HOLD
688575.SS	Shenzhen YHLO Biotech Co., Ltd.	$870M	26	SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) — Stock Score Summary

Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) has a MoatMap StockRank of 42/100 based on Quality (39/100), Value (47/100), and Momentum (47/100) factor scores. The current signal is HOLD. Zhejiang Orient Gene Biotech is an in-vitro diagnostics manufacturer. It is a low-moat business with declining post-COVID revenues and no connection to high-conviction macro themes.

Key Financial Metrics

Price	$2.85
Market Cap	$638M
P/E (Forward)	0.73
Price/Book	0.63
Return on Equity	-9.1%
Return on Invested Capital	-9.1%
Debt/Equity	5.45
Gross Margin	41.3%
Operating Margin	-29.0%
Revenue Growth	33.5%
Free Cash Flow	$-10M

Zhejiang Orient Gene Biotech Co., Ltd operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Orient Gene Biotech Co., Ltd’s (688298.SS) StockRank?: MoatMap’s StockRank for Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) is 42/100, with a Hold signal. It is a composite of Quality (39), Value (47), and Momentum (47) factor ranks across MoatMap’s 20,000+ stock universe.
Does Zhejiang Orient Gene Biotech Co., Ltd have an economic moat?: Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Orient Gene Biotech Co., Ltd a buy, hold, or sell?: MoatMap’s current signal for Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) is Hold, based on a StockRank of 42/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Orient Gene Biotech Co., Ltd in?: Zhejiang Orient Gene Biotech Co., Ltd (688298.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).